Pulmonary Function of Tuberculosis Patients in Medication at Dr. Hasan Sadikin General Hospital Bandung 2013–2014

Main Authors: Pradipta, Shalahuddin Galih, Suryadinata, Hendarsyah, Setiawan, Setiawan
Format: Article info application/pdf eJournal
Bahasa: eng
Terbitan: Althea Medical Journal , 2018
Subjects:
Online Access: http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189
http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189/1078
ctrlnum article-1189
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><title lang="en-US">Pulmonary Function of Tuberculosis Patients in Medication at Dr. Hasan Sadikin General Hospital Bandung 2013&#x2013;2014</title><creator>Pradipta, Shalahuddin Galih</creator><creator>Suryadinata, Hendarsyah</creator><creator>Setiawan, Setiawan</creator><subject lang="en-US"/><subject lang="en-US">Lung, restrictive, spirometry, tuberculosis</subject><description lang="en-US">Background: Tuberculosis (TB) is a dangerous global disease that already affects millions of people in the world and acts as the second most frequent cause of death in infectious diseases. Tuberculosis mostly attacks the lung and the inflammation process causes lung damage. The lung damage causes a decrease in pulmonary function. There has been no study about tuberculosis patient lung function in the advanced stage of medication.Methods: This study was conducted from August&#x2013;October 2014 at DOTS Policlinic of Dr. Hasan Sadikin General Hospital Bandung. The study population was lung TB patients. The inclusion criteria were 1st category lung TB patients with anti-TB drug treatment on intensive phase. The exclusion criteria were extrapulmonary TB patients, patients with lung surgery history, and patients with asthma or chronic obstructive pulmonary disease (COPD). This study used purposive sampling. The subjects were given a spirometry test where the forced expiratory volume 1 second (FEV1), forced vital capacity (FVC), and their ratio were collected and then interpreted.Results: Among the 60 subjects included in this study, the data showed that 83.4% of the subjects had a decreased pulmonary function consisting of obstructive (6.7%) and restrictive patterns (76.7%).Conclusions: The majority of pulmonary TB patients treated with 1st category anti-TB drugs during intensive phase have a decrease in pulmonary function and most of them have restrictive pattern of pulmonary function.</description><publisher lang="en-US">Althea Medical Journal</publisher><publisher lang="id-ID">Althea Medical Journal</publisher><contributor lang="en-US"/><date>2018-01-11</date><type>Journal:Article</type><type>Other:info:eu-repo/semantics/publishedVersion</type><type>Other:</type><type>Other:</type><type>File:application/pdf</type><identifier>http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189</identifier><source lang="en-US">Althea Medical Journal; Vol 4, No 3 (2017); 402-406</source><source lang="id-ID">Althea Medical Journal; Vol 4, No 3 (2017); 402-406</source><source>2337-4330</source><source>10.15850/amj.v4n3</source><language>eng</language><relation>http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189/1078</relation><rights lang="en-US">Copyright (c) 2017 Althea Medical Journal</rights><rights lang="en-US">http://creativecommons.org/licenses/by-nc/4.0</rights><recordID>article-1189</recordID></dc>
language eng
format Journal:Article
Journal
Other:info:eu-repo/semantics/publishedVersion
Other
Other:
File:application/pdf
File
Journal:eJournal
author Pradipta, Shalahuddin Galih
Suryadinata, Hendarsyah
Setiawan, Setiawan
title Pulmonary Function of Tuberculosis Patients in Medication at Dr. Hasan Sadikin General Hospital Bandung 2013–2014
publisher Althea Medical Journal
publishDate 2018
topic Lung
restrictive
spirometry
tuberculosis
url http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189
http://journal.fk.unpad.ac.id/index.php/amj/article/view/1189/1078
contents Background: Tuberculosis (TB) is a dangerous global disease that already affects millions of people in the world and acts as the second most frequent cause of death in infectious diseases. Tuberculosis mostly attacks the lung and the inflammation process causes lung damage. The lung damage causes a decrease in pulmonary function. There has been no study about tuberculosis patient lung function in the advanced stage of medication.Methods: This study was conducted from August–October 2014 at DOTS Policlinic of Dr. Hasan Sadikin General Hospital Bandung. The study population was lung TB patients. The inclusion criteria were 1st category lung TB patients with anti-TB drug treatment on intensive phase. The exclusion criteria were extrapulmonary TB patients, patients with lung surgery history, and patients with asthma or chronic obstructive pulmonary disease (COPD). This study used purposive sampling. The subjects were given a spirometry test where the forced expiratory volume 1 second (FEV1), forced vital capacity (FVC), and their ratio were collected and then interpreted.Results: Among the 60 subjects included in this study, the data showed that 83.4% of the subjects had a decreased pulmonary function consisting of obstructive (6.7%) and restrictive patterns (76.7%).Conclusions: The majority of pulmonary TB patients treated with 1st category anti-TB drugs during intensive phase have a decrease in pulmonary function and most of them have restrictive pattern of pulmonary function.
id IOS74.article-1189
institution Universitas Padjadjaran
institution_id 16
institution_type library:university
library
library Perpustakaan Universitas Padjadjaran
library_id 572
collection Althea Medical Journal
repository_id 74
subject_area Farmasi
city BANDUNG
province JAWA BARAT
repoId IOS74
first_indexed 2018-01-31T18:07:15Z
last_indexed 2020-01-19T21:00:09Z
recordtype dc
_version_ 1680113264222011392
score 17.177858